Clinical Trial Update: 3TC or No 3TC for HIV With 3TC Resistance [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing lamivudine (3TC) versus no lamivudine in HIV infection with 3TC resistance has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 3TC (Lamivudine)

Snippet

Sponsor: University of British Columbia | Conditions: HIV Infections | Phase 4 | Status: SUSPENDED